1
|
Hogervorst MA, Vreman R, Heikkinen I, Oortwijn W. Response to uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group - author's reply. Int J Technol Assess Health Care 2023; 40:e1. [PMID: 38108142 PMCID: PMC10859829 DOI: 10.1017/s0266462323002817] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2023] [Accepted: 11/30/2023] [Indexed: 12/19/2023]
Affiliation(s)
- Milou Amber Hogervorst
- Utrecht University, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht, The Netherlands
| | - Rick Vreman
- Utrecht University, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht, The Netherlands
| | | | - Wija Oortwijn
- Radboud University Medical Centre, Department for Health Evidence, Nijmegen, The Netherlands
| |
Collapse
|